-
1دورية أكاديمية
المؤلفون: Lee‐Moay Lim, Yi‐Chen Lee, Ting‐Wei Lin, Zi‐Xuan Hong, Wei‐Chi Hsu, Hung‐Lung Ke, Daw‐Yang Hwang, Wen‐Yu Chung, Wei‐Ming Li, Hui‐Hui Lin, Hung‐Tien Kuo, A‐Mei Huang
المصدر: Kaohsiung Journal of Medical Sciences, Vol 40, Iss 5, Pp 445-455 (2024)
مصطلحات موضوعية: AKT‐mTOR pathway, neurotrophic receptor tyrosine kinase 3 (NTRK3), prognosis, tropomyosin‐related kinase (TrK), upper tract urothelial carcinoma (UTUC), Medicine (General), R5-920
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Shuang Xiang, Xiaoyun Lu
المصدر: Acta Pharmaceutica Sinica B, Vol 14, Iss 2, Pp 517-532 (2024)
مصطلحات موضوعية: NTRK fusions, TRK kinase, Clinical resistance, xDFG mutations, Selective type II inhibitors, Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
العلاقة: http://www.sciencedirect.com/science/article/pii/S2211383523004331Test; https://doaj.org/toc/2211-3835Test
-
3
المؤلفون: Önnestam, K., Nilsson, B., Rother, M., Rein-Hedin, Erik, Bylund, J., Anderer, P., Kemethofer, M., Halldin, M. M., Sandin, J., Segerdahl, Märta
المصدر: The Journal of Prevention of Alzheimer's Disease. 10(4):778-789
مصطلحات موضوعية: Alzheimer's Disease, ACD856, neurotrophin, multiple ascending doses, Trk
وصف الملف: electronic
الوصول الحر: https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-519956Test
https://doi.org/10.14283/jpad.2023.89Test
https://uu.diva-portal.org/smash/get/diva2:1827114/FULLTEXT01.pdfTest -
4دورية أكاديمية
المؤلفون: Cansu Karakas, Ellen J. Giampoli, Tanzy Love, David G. Hicks, Moises J. Velez
المصدر: Diagnostic Pathology, Vol 19, Iss 1, Pp 1-13 (2024)
مصطلحات موضوعية: Pan-TRK, NTRK, Immunohistochemistry, Interpretation, Validation, Pathology, RB1-214
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/1746-1596Test
-
5دورية أكاديمية
المؤلفون: Valeriy V. Breder, Liudmila G. Zhukova, Larisa V. Bolotina, Irina A. Demidova, Yaroslav A. Zhulikov, Elena V. Lubennikova, David R. Naskhletashvili, Sergey V. Orlov, Rashida V. Orlova, Ilya S. Romanov, Nikita A. Savelov, Ksenia A. Sarantseva, Alexandra S. Tyulyandina, Mikhail Yu. Fedyanin
المصدر: Современная онкология, Vol 25, Iss 3, Pp 295-300 (2023)
مصطلحات موضوعية: ntrk gene fusions, entrectinib, trk inhibitors, molecular testing in solid tumors, secretory carcinoma, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: https://modernonco.orscience.ru/1815-1434/article/viewFile/159394/pdfTest; https://doaj.org/toc/1815-1434Test; https://doaj.org/toc/1815-1442Test
-
6دورية أكاديمية
المؤلفون: Marika Quadri, Elisabetta Palazzo
المصدر: JID Innovations, Vol 4, Iss 5, Pp 100295- (2024)
مصطلحات موضوعية: CD271, cSCC, Neurotrophins, TRK receptors, Zebrafish models, Dermatology, RL1-803
وصف الملف: electronic resource
العلاقة: http://www.sciencedirect.com/science/article/pii/S2667026724000420Test; https://doaj.org/toc/2667-0267Test
-
7دورية أكاديمية
المؤلفون: Zichao Xu, Xia Peng, Renjie Zhang, Yinchun Ji, Mengke You, Danyi Wang, Yanyan Shen, Mingyue Zheng, Chunpu Li, Jing Ai, Hong Liu
مصطلحات موضوعية: Biochemistry, Cell Biology, Pharmacology, Biotechnology, Cancer, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, dependent cell viability, based drug design, >)‑ one analogues, >)- one scaffold, tumor growth inhibition, thereby inhibiting trk, potent trk inhibitors, potent trk inhibitor, promising hit compound, good kinase selectivity, 4 b, 14q b, vivo <, tumor occurrence, h <, subcutaneous m091, oral bioavailability, oncogenic form, novel pyridin
الإتاحة: https://doi.org/10.1021/acs.jmedchem.3c01645.s001Test
https://figshare.com/articles/journal_contribution/Discovery_Optimization_and_Evaluation_of_Novel_Pyridin-2_1_i_H_i_one_Analogues_as_Potent_TRK_Inhibitors_for_Cancer_Treatment/25008519Test -
8دورية أكاديمية
المؤلفون: Sherzod Aburasulovich, Sherov
المصدر: WORLD OF SCIENCE; Vol. 7 No. 5 (2024): WORLD OF SCIENCE; 72-82
مصطلحات موضوعية: GAMK (gmma amino moy kislota), NGF (nerv o’sish faktori), BDNF (miyadan olingan neyrotrofik faktor), GSK-3 (glikogen sintaz kinaza), TRK (tirozin kinaza), HIF (gipoksiyani qo'zg'atuvchi faktor)
وصف الملف: application/pdf
-
9دورية أكاديمية
المؤلفون: Zoccali, Federica, Arienzo, Francesca, Casini, Beatrice, Covello, Renato, de Vincentiis, Marco, Riminucci, Mara, Corsi, Alessandro
المساهمون: Zoccali, Federica, Arienzo, Francesca, Casini, Beatrice, Covello, Renato, de Vincentiis, Marco, Riminucci, Mara, Corsi, Alessandro
مصطلحات موضوعية: parotid, secretory carcinoma, macrocystic secretory carcinoma, pan- TRK immunohistochemistry, ETV6 gene rearrangement
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/38400728; firstpage:1; lastpage:3; numberofpages:3; journal:EAR, NOSE & THROAT JOURNAL; https://hdl.handle.net/11573/1704284Test
-
10دورية أكاديمية
المؤلفون: Sohita Dhillon
مصطلحات موضوعية: Medicine, Repotrectinib, Adis Insight Report, Adis Drug Review, ROS1 inhibitor, TRK inhibitor, small-molecule kinase inhibitor
الإتاحة: https://doi.org/10.6084/m9.figshare.24863055.v1Test
https://figshare.com/articles/online_resource/Repotrectinib_First_Approval/24863055Test